Ding Li,邓彬,陈刚.RNA therapeutics targeting PD-L1 is a promising immune-activation strategy against difficult-to-treat cancers.MOLECULAR THERAPY,2024,32(8)2439-2440.

Ding Li,徐玉洁,徐林,赵晨宏,张智萍,张杰,张新跃,廖凯.Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells.ONCOGENESIS,2023,12(1)

Ding Li,赵晨宏,徐玉洁,张智萍,聂也森,廖凯,Xinyue Zhang,陈玥柔.Mutations in DNA binding domain of p53 impede RSL1D1-p53 interaction to escape from degradation in human colorectal cancer cells.EXPERIMENTAL CELL RESEARCH,2022,417(1)

Ding Li,高清清,许卓斌,蔡良良,陈素娟,Xinyue Zhang,曹鹏,陈刚.An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer.ADVANCED SCIENCE,2022,9(2)

Ding Li,徐玉洁,徐林,赵晨宏,张智萍,张杰,Xinyue Zhang,廖凯.Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells.ONCOGENESIS,2023,12(1)

Ding Li,赵晨宏,徐玉洁,张智萍,聂也森,廖凯,陈玥柔.Mutations in DNA binding domain of p53 impede RSL1D1-p53 interaction to escape from degradation in human colorectal cancer cells.EXPERIMENTAL CELL RESEARCH,2022,417(1)

Ding Li,高清清,许卓斌,蔡良良,陈素娟,Xinyue Zhang,曹鹏.An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer.ADVANCED SCIENCE,2022,9(2)

Ding Li,张智萍,赵晨宏,陈磊,陈志强,张杰,刘雅娴,Xinyue Zhang.Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2021,40(1)

Ding Li,Xinyue Zhang.靶向突变型p53的抗肿瘤药物研究进展.扬州大学学报:农业与生命科学版,2020,41(6)57-63.

Ding Li,Xinyue Zhang.纳米金用于肿瘤免疫治疗的研究进展.中国肿瘤,2021,30(1)58-66.